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Primary Leiomyosarcoma of the Inferior Vena Cava and
Interposition of a Bovine Pericardial Graft
R. Karmeli*, A. Eyal, S. Eldar and S. Fajer
Department of Vascular Surgery, Carmel Medical Center, Haifa, Israel
Primary leiomyosarcoma of the inferior vena cava (IVC) is a rare disease with fewer than 220 cases reported in the literature.
Symptoms usually develop late in the course of the disease delaying the diagnosis and worsening the prognosis. Curative
treatment consists of total surgical resection of the tumour with interposition grafting for the missing portion of the IVC.
The reported 5 year survival rate ranges from 37 to 53%.
We report a case of a 58-year-old female with primary leiomyosarcoma of the juxtarenal IVC diagnosed incidentally on
abdominal ultrasound. After further investigation by computerised tomography angiography (CTA), the tumour was
removed completely with clear surgical margins. Bovine pericardium was used as an interposition graft for the resected
portion of IVC. Some advantages of using this material for venous bypass include its versatile diameter options, malleability,
minimal needle hole ooze and less potential for infection in comparison to synthetic grafts [Vasc. Endovasc. Surg. 37 (2003)
225]. Further research is needed regarding the patency rate, late infection and overall success.
We believe a high index of suspicion is crucial for the early diagnosis of this disease. An aggressive surgical approach is
necessary for optimal survival.
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Introduction
Tumours of the inferior vena cava (IVC) can be
primary or secondary in origin. Primary tumours
arise from the vessel wall, while secondary ones
originate in adjacent tissue and invade the IVC by
direct spread.2
Primary leiomyosarcoma of the IVC is a rare finding
with fewer than 220 cases reported in the literature.3
The first case was reported in 1871, identified on a
post-mortem examination. A late diagnosis with
metastases complicates the surgical treatment and
leads to a relatively poor prognosis. Several recent
cases have been published reporting the diagnosis and
treatment of leiomyosarcomata of the IVC.1,4,5 The
recommended treatment includes complete surgical
resection with the role of adjuvent therapy remaining
unclear. The 5 and 10 year survival rates of these
tumours are 38 and 14%, respectively.3,4
Case Report
A 58-year-old female with a previous history of
hypertension and hypercholesterolæmia presented
with nonspecific right sided abdominal pain, a single
episode of 38 8C fever, fatigue and weight loss.
Physical examination was unremarkable apart from
mild right-sided abdominal tenderness. No abdominal
mass could be felt and there was no sign of lower limb
œdema or venous engorgement. An abdominal ultra-
sound ruled out biliary pathology but identified an
abnormal juxtarenal mass in the IVC. Abdominal CTA
revealed a central intraluminal mass arising from the
dorsal aspect of the IVC, with dilation of the lumen,
and possible involvement of the right kidney and the
right adrenal gland (Fig. 1). Further investigation
included a chest X-ray, echocardiogram and chest
CTA, which ruled out cardiac or pulmonary artery
involvement and metastatic disease. The patient was
started on IV heparin to prevent vena cava thrombosis,
and was scheduled for surgery.
The tumour was successfully removed with the
involved portion of the IVC and the pre-vertebral
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fascia, sparing both renal veins (Figs. 2 and 3). A
bovine pericardial patch was used to create an
interposition graft (Fig. 4).
On the first post-operative day, a decrease in
hæmoglobin levels was noted along with distention
and rigidity of the abdomen. A CTA was performed
which showed active retroperitoneal hemorrhage. The
patient was re-explored and a bleeding lumbar artery
was sutured. The post-operative course was otherwise
uneventful. The patient was discharged on the 10th
post-operative day with anticoagulant therapy.
Pathological exam showed that the resection mar-
gins were clear. A follow-up CTA conducted twelve
months post-operatively demonstrated a patent graft
with no evidence of local recurrence.
Discussion
Primary leiomyosarcoma of the IVC is a rare finding,
more common in females, and usually presenting in
the sixth and seventh decades.2 – 4 Diagnosis is often
delayed because the disease is relatively asympto-
matic. Symptoms and signs include abdominal pain
(66%), abdominal mass (48%), lower limb œdema
(39%), weight loss (30.6%) and Budd–Chiari syn-
drome (22.2%). Additional nonspecific symptoms
reported include fever, weakness, anorexia, nausea,
vomiting, nocturnal sweating and dyspnœa—some
attributed to metastasis.2
Diagnosis depends on specialised imaging tech-
niques. Doppler ultrasonography usually enables
visualization of the entire vena cava and defines
patency as well as the presence and extent of an
intraluminal thrombus. CT and MRI identify not only
the presence of a tumour but give valuable infor-
mation regarding localized spread and distant metas-
tasis. Venography is important in cases of IVC
occlusion in order to demonstrate collateral flow and
plan surgical strategy. Pre-operative intraluminal
biopsy is useful when differentiation from a thrombus
is difficult.2
For those patients diagnosed early, the optimal
treatment consists of total surgical excision with
prosthetic interposition grafting.6 Reconstruction of
Fig. 1. Abdominal CTA—sagittal reconstruction view show-
ing IVC tumour (arrow).
Fig. 2. Abdominal IVC tumour (Tu), abdominal aorta (Ao),
left renal vein (LRV).
Fig. 3. Anterior venectomy with tumour bulging into the
lumen (arrow).
Fig. 4. Interposition graft constructed from bovine
pericardium.
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the resected portion diminishes symptoms of lower
limb venous engorgement following surgery.6 The
response to chemotherapy and radiotherapy is vari-
able, although some reports show benefit from radio-
therapy for control of local disease.7 We prefer
anticoagulant therapy following IVC resection,
although the issue is controversial.6
Resectability of the tumour is the primary factor
affecting the prognosis. Late diagnosis and/or invol-
vement of the suprarenal vena cava both complicate
the surgical approach and worsen the prognosis. The
reported 5-year survival of patients with primary
leiomyosarcoma of the IVC is 53%, similar to that of
retroperitoneal leiomyosarcomata.7
In our case, early diagnosis and sole involvement of
the juxtarenal IVC allowed total resection. A bovine
pericardial patch was used as an interposition graft in
the abdominal IVC.
A literature search revealed one other case where
bovine pericardium was used as an interposition graft
of the abdominal IVC.1 The pericardial patch has also
been used in other cases but not as interposition grafts.
Our use of the pericardial patch as an interposition
graft seemed more appropriate than using a synthetic
graft due to the versatile diameter options. Other
advantages include its friendly management and less
frequent bleeding after needle puncture.1
In the present instance a follow-up CTA showed
patency of the graft 12 months after the operation,
suggesting the adequacy of biological grafts in such a
setting. We believe that a high index of suspicion for
the early diagnosis of primary leiomyosarcoma of the
IVC combined with an aggressive surgical approach
improves the survival of these patients. The use of a
bovine pericardial patch is an option in selected cases,
offering some advantages over synthetic grafts.
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